MedTrace Logo

Seven vs. 14 Days Treatment for Male Urinary Tract Infection

NCT01994538 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 273

Last updated 2021-06-02

Study results available
· View outcomes & findings →

Summary

This study will investigate the treatment of urinary tract infection in men. Specifically, the investigators are looking to see if shorter duration of antibiotics (7 days) is any worse than longer duration of antibiotics (14 days). The investigators will also study whether longer treatment leads to an increase in antibiotic resistant bacteria in the large intestine (colon), or an increase in drug side effects.

Conditions

Interventions

OTHER

Longer therapy duration

14 days of antimicrobial treatment

OTHER

Shorter therapy duration

7 days of antimicrobial treatment

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Dimitri M Drekonja, MD · Minneapolis VA Health Care System, Minneapolis, MN

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-24
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01994538 on ClinicalTrials.gov